Results 21 to 30 of about 31,799 (185)

A novel mutation of the MEN1 gene in a patient with multiple endocrine neoplasia type 1 and recurrent fibromyxoid sarcoma – a case report

BMC Medical Genetics, 2020
Background Multiple endocrine neoplasia type 1 (MEN1) syndrome is usually accompanied by endocrine tumors, but non-endocrine tumors can occur as well. However, the coexistence of MEN1 syndrome and malignant tumor such as low-grade fibromyxoid sarcoma has
Maja Radman, Tanja Milicevic
doaj   +1 more source

Hedinger Syndrome—Lessons Learnt: A Single-Center Experience

Journal of Cardiovascular Development and Disease, 2023
Background: Hedinger syndrome (HS) or carcinoid heart disease (CD) is a rare and challenging manifestation of malignant neuroendocrine tumours (NETs) involving the heart.
Mohamed El Gabry, Sven Arends, Sharaf-Eldin Shehada, Harald Lahner, Markus Kamler, Daniel Wendt, Konstantina Spetsotaki   +6 more
doaj   +1 more source

Carcinoid syndrome due to a malignant somatostatinoma [PDF]

Postgraduate Medical Journal, 1995
Abstract Somatostatinoma is one of the rarest tumours of the endocrine pancreas. Cardinal manifestations of a somatostatinoma include gallstones, mild diabetes mellitus, steatorrhoea, diarrhoea and dyspepsia. Like any other pancreatic islet cell carcinoma, a somatostatinoma may also produce several different hormones such as ...
O, Ozbakir, F, Keleştimur, F, Oztürk, E, Sözüer, A, Unal, T E, Patiroğlu, K, Güven   +6 more
openaire   +4 more sources

Primary carcinoid tumors at atypical sites: surgery is mandatory and size determines survival—an Egyptian study

Bulletin of the National Research Centre, 2019
Background Carcinoids at atypical sites are rare and mostly asymptomatic. In the majority, they show normal levels of serotonin and its metabolites in plasma and urine, resulting in a relatively late diagnosis and hence guarded prognosis.
Karim G. Moustafa, Gamal M. Saied
doaj   +1 more source

High-Dose Lanreotide in the Treatment of Poorly Differentiated Pancreatic Neuroendocrine Carcinoma: A Case Report

Case Reports in Oncology, 2014
Pancreatic neuroendocrine tumors (NETs), including poorly differentiated carcinomas (NECs), are rarely encountered. The majority of these tumors do not secrete excess hormones, but functioning NETs produce large amounts of vasoactive peptides and may ...
Frank Van Fraeyenhove, Nathalie Meireson, Luc Terriere, Paul Willemsen, Jan Kunnen, Caroline Mattelaer, Frank Van Acker, Dirk Schrijvers   +7 more
doaj   +1 more source

Expressions of Cushing’s syndrome in multiple endocrine neoplasia type 1

Frontiers in Endocrinology, 2023
Cushing’s syndrome (CS) resulting from endogenous hypercortisolism can be sporadic or can occur in the context of familial disease because of pituitary or extra-pituitary neuroendocrine tumors.
William F. Simonds
doaj   +1 more source

Targeted treatment with somatostatin analogues: widening horizons of clinical practice

Alʹmanah Kliničeskoj Mediciny, 2022
Targeted treatment with somatostatin analogues (SA) in acromegaly and neuroendocrine neoplasms may have some benefits compared to curative treatments, because these agents decrease excessive hormone secretion and exert a tumor-suppressive effect ...
Vyacheslav S. Pronin, Mikhail B. Antsiferov, Tatiana M. Alexeeva, Evgeny V. Pronin   +3 more
doaj   +1 more source

MDCT imaging in malignant carcinoid syndrome [PDF]

Indian Journal of Gastroenterology, 2011
A 65-year-old lady presented with sudden onset of palpitations, headache, perspirations and flushing. Clinical examination revealed tenderness in right lumbar region. Ultrasound abdomen revealed multiple hyperechoic hepatic lesions and a mesenteric mass.
Kamini, Gupta, Samarjit, Kaur, Ranjana, Gupta, Amit, Goyal   +3 more
openaire   +2 more sources

Ectopic ACTH Cushing's syndrome caused by a large-cell neuroendocrine lung carcinoma responding to desmopressin

Endocrine Oncology, 2023
Ectopic adrenocorticotrophic hormone (ACTH) secretion (EAS) is a rare cause of ACTH-dependent Cushing’s syndrome (CS), most often caused by a thoracic neuroendocrine tumor (NET).
Stéphanie Larose, Dany Rioux, Roula Albadine, André Lacroix   +3 more
doaj   +1 more source

Serotoninergic brain dysfunction in neuroendocrine tumor patients: A scoping review

Comprehensive Psychiatry, 2021
Introduction: Neuroendocrine tumors (NETs) are rare and malignant neoplasms characterized by their potential to produce metabolically active substances with the capacity to bring about clinical syndromes.
Anna La Salvia, Alberto Portigliatti Pomeri, Irene Persano, Elena Trevisi, Elena Parlagreco, Nicoletta Colombi, Maria Pia Brizzi, Rocco Luigi Picci, Francesco Oliva   +8 more
doaj   +1 more source